Journal of the American Society of Hypertension
Volume 2, Issue 5 , Pages 355-365.e2 , September 2008

Treatment of elderly hypertensive patients with epithelial sodium channel inhibitors combined with a thiazide diuretic reduces coronary mortality and sudden cardiac death

  • Patricia R. Hebert, PhD

      Affiliations

    • Section of Cardiovascular Medicine, Department of Medicine, Yale University School of Medicine, New Haven, Connecticut, USA
    • ,
  • Christopher S. Coffey, PhD

      Affiliations

    • Department of Biostatistics, University of Alabama at Birmingham, Birmingham, Alabama, USA
    • ,
  • Daniel W. Byrne, MS

      Affiliations

    • Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, Tennessee, USA
    • ,
  • Theresa A. Scott, MS

      Affiliations

    • Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, Tennessee, USA
    • ,
  • Robert H. Fagard, MD, PhD

      Affiliations

    • Hypertension and Cardiovascular Rehabilitation Unit, University of Leuven K. U. Leuven, Leuven, Belgium
    • ,
  • Jeffrey N. Rottman, MD

      Affiliations

    • Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA
    • Division of Cardiovascular Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA
    • ,
  • Katherine T. Murray, MD

      Affiliations

    • Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA
    • Division of Clinical Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee, USA
    • Division of Cardiovascular Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA
    • ,
  • John A. Oates, MD

      Affiliations

    • Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA
    • Division of Clinical Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee, USA
    • Corresponding Author InformationCorresponding author: John A. Oates, MD, Vanderbilt Medical Center, 536 RRB, Nashville, Tennessee 37232. Tel: 615-343-4847; fax: 615-322-5303

Received 22 February 2008 ,Accepted 1 April 2008.

References 

  1. Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, Eberlein KA, et al. Blood pressure, stroke, and coronary heart disease (Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context). Lancet. 1990;335:827–838
  2. Hoes AW, Grobbee DE, Lubsen J, Man in't Veld AJ, van der Does E, Hofman A. Diuretics, beta-blockers, and the risk for sudden cardiac death in hypertensive patients. Ann Intern Med. 1995;123:481–487
  3. Siscovick DS, Raghunathan TE, Psaty BM, Koepsell TD, Wicklund KG, Lin X, et al. Diuretic therapy for hypertension and the risk of primary cardiac arrest. N Engl J Med. 1994;330:1852–1857
  4. Garan H, McGovern BA, Canzanello VJ, McCauley J, Bodvarsson M, Harrington JT, et al. The effect of potassium ion depletion on postinfarction canine cardiac arrhythmias. Circulation. 1988;77:696–704
  5. Hohnloser SH, Verrier RL, Lown B, Raeder EA. Effect of hypokalemia on susceptibility to ventricular fibrillation in the normal and ischemic canine heart. Am Heart J. 1986;112:32–35
  6. Curtis MJ, Hearse DJ. Ischaemia-induced and reperfusion-induced arrhythmias differ in their sensitivity to potassium: implications for mechanisms of initiation and maintenance of ventricular fibrillation. J Mol Cell Cardiol. 1989;21:21–40
  7. MRC Working Party. Medical Research Council trial of treatment of hypertension in older adults: principal results. BMJ. 1992;304:405–412
  8. Amery A, Birkenhager W, Brixko P, Bulpitt C, Clement D, Deruyttere M, et al. Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial. Lancet. 1985;1:1349–1354
  9. Dahlof B, Lindholm LH, Hansson L, Schersten B, Ekbom T, Wester PO. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Lancet. 1991;338:1281–1285
  10. Grobbee DE, Hoes AW. Non-potassium-sparing diuretics and risk of sudden cardiac death. J Hypertens. 1995;13:1539–1545
  11. Hebert PR, Moser M, Mayer J, Glynn RJ, Hennekens CH. Recent evidence on drug therapy of mild to moderate hypertension and decreased risk of coronary heart disease. Arch Intern Med. 1993;153:578–581
  12. Psaty BM, Lumley T, Furberg CD, Schellenbaum G, Pahor M, Alderman MH, et al. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis. JAMA. 2003;289:2534–2544
  13. Staessen JA, Gasowski J, Wang JG, Thijs L, Den Hond E, Boissel JP, et al. Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials. Lancet. 2000;355:865–872
  14. Borhani NO, Blaufox MD, Oberman A, Polk BF. Incidence of coronary heart disease and left ventricular hypertrophy in the Hypertension Detection and Follow-up Program. Prog Cardiovasc Dis. 1986;29:S55–S62
  15. Multiple Risk Factor Intervention Trial Research Group. Multiple risk factor intervention trial (Risk factor changes and mortality results). JAMA. 1982;248:1465–1477
  16. Medical Research Council Working Party on Mild Hypertension. Coronary heart disease in the Medical Research Council trial of treatment of mild hypertension. Br Heart J. 1988;59:364–378
  17. Smith WM. Treatment of mild hypertension: results of a ten-year intervention trial. Circ Res. 1977;40:I98–I105
  18. Evaluation of drug treatment in mild hypertension: VA-NHLBI feasibility trial (Plan and preliminary results of a two-year feasibility trial for a multicenter intervention study to evaluate the benefits versus the disadvantages of treating mild hypertension. Prepared for the Veterans Administration-National Heart, Lung, and Blood Institute Study Group for Evaluating Treatment in Mild Hypertension). Ann N Y Acad Sci. 1978;304:267–292
  19. Coope J, Warrender TS. Randomised trial of treatment of hypertension in elderly patients in primary care. Br Med J (Clin Res Ed). 1986;293:1145–1151
  20. Effects of treatment on morbidity in hypertension (Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg). JAMA. 1967;202:1028–1034
  21. The Australian therapeutic trial in mild hypertension (Report by the Management Committee). Lancet. 1980;1:1261–1267
  22. Effects of treatment on morbidity in hypertension (II. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg). JAMA. 1970;213:1143–1152
  23. PATS Collaborating Group. Post-stroke antihypertensive treatment study (A preliminary result). Chin Med J (Engl). 1995;108:710–717
  24. Control of moderately raised blood pressure (Report of a co-operative randomized controlled trial). Br Med J. 1973;3:434–436
  25. Carter AB. Hypotensive therapy in stroke survivors. Lancet. 1970;1:485–489
  26. Hypertension-Stroke Cooperative Study Group. Effect of antihypertensive treatment on stroke recurrence. JAMA. 1974;229:409–418
  27. Helgeland A. Treatment of mild hypertension: a five year controlled drug trial (The Oslo Study). Am J Med. 1980;69:725–732
  28. Perry HM, Smith WM, McDonald RH, Black D, Cutler JA, Furberg CD, et al. Morbidity and mortality in the Systolic Hypertension in the Elderly Program (SHEP) pilot study. Stroke. 1989;20:4–13
  29. Bulpitt CJ, Beckett NS, Cooke J, Dumitrascu DL, Gil-Extremera B, Nachev C, et al. Results of the pilot study for the Hypertension in the Very Elderly Trial. J Hypertens. 2003;21:2409–2417
  30. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension (Final results of the Systolic Hypertension in the Elderly Program (SHEP)). JAMA. 1991;265:3255–3264
  31. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–188
  32. Egger M, Smith G, Altman D. Systematic Reviews in Health Care: Meta-analysis in Context. 2nd edition. London, England: BMJ Publishing Co; 2001;146–47, 364
  33. Altman D, Machin D, Bryant T, Gardner M. Statistics with Confidence — Confidence Intervals and Statistical Guidelines. 2nd edition. London, England: British Medical Journal; 2000;
  34. Saha C, Eckert GJ, Ambrosius WT, Chun TY, Wagner MA, Zhao Q, et al Improvement in blood pressure with inhibition of the epithelial sodium channel in blacks with hypertension. Hypertension. 2005;46:481–487
  35. Burke AP, Farb A, Malcom GT, Liang Y, Smialek JE, Virmani R. Plaque rupture and sudden death related to exertion in men with coronary artery disease. JAMA. 1999;281:921–926
  36. Davies MJ, Thomas A. Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death. N Engl J Med. 1984;310:1137–1140
  37. Spaulding CM, Joly LM, Rosenberg A, Monchi M, Weber SN, Dhainaut JF, et al. Immediate coronary angiography in survivors of out-of-hospital cardiac arrest. N Engl J Med. 1997;336:1629–1633
  38. Campbell SE, Janicki JS, Matsubara BB, Weber KT. Myocardial fibrosis in the rat with mineralocorticoid excess (Prevention of scarring by amiloride). Am J Hypertens. 1993;6:487–495
  39. Schatzkin A, Cupples LA, Heeren T, Morelock S, Kannel WB. Sudden death in the Framingham Heart study (Differences in incidence and risk factors by sex and coronary disease status). Am J Epidemiol. 1984;120:888–899
  40. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457–481

 This work was supported, in part, by a grant from the National Institute of General Medical Sciences (GM 15431). Dr. Oates is the Thomas F. Frist, Sr. Professor of Medicine and is a consultant for Merck. Supplemental Material is available at www.ashjournal.com.

PII: S1933-1711(08)00046-6

doi: 10.1016/j.jash.2008.04.001

Journal of the American Society of Hypertension
Volume 2, Issue 5 , Pages 355-365.e2 , September 2008

Article Tools

* Image Usage & Resolution